Scaling Innovations in Global Health

¿Scaling Innovations in Global Health: Sproxil¿Using Technology to Guard Against Counterfeit Drugs in the Developing World¿5:45p.m., Fuqua School of Business, Lilly ClassroomLight reception to followAn estimated 15% of drugs sold in the world are fake¿in Africa and Asia this figure can range from 10% to 30%. Sproxil (http://sproxil.com ) is a SEAD global health enterprise that provides world-class brand protection in emerging markets through software and services that work anywhere there are mobile phones, allowing patients to ensure at the moment of purchase that their drugs are from reputable providers. Join us as Sproxil¿s CFO and chief strategist Alden Zecha discusses the challenges in scaling their pharmaceutical anti-counterfeiting technology globally.